About atogepant
Calcitonin gene-related peptide receptor antagonist
Used for
- Prevention of migraine in adults.
Usual adult dose
60 mg by mouth once daily.
Common side effects
- Nausea
- Constipation
- Fatigue or sleepiness
- Decreased appetite
Important warnings
- Serious allergic reactions can occur.
- Constipation can rarely become severe.
- Avoid strong CYP3A4 inhibitors and inducers; they can alter drug levels.
- Dose changes may be needed with certain medicines or severe kidney impairment.
Pregnancy
Human pregnancy data are limited; safety is not established.
Breastfeeding
It is unknown whether atogepant passes into breast milk; effects on infants are uncertain.
Interactions
- Strong CYP3A4 inhibitors can increase atogepant levels.
- Strong CYP3A4 inducers can reduce its effectiveness.
- OATP inhibitors can increase atogepant levels.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.